Globus Medical (GMED) EBITDA Margin: History & Chart

Globus Medical, Inc.(GMED)

Medical - Devices · Audubon, PA

$82.54-0.56 (-0.67%)

Delayed quote: Aug 27, 2026, 4:00 PM EDT

About Globus Medical, Inc.

Globus Medical, Inc. is a global medical technology company dedicated to inventing, developing, and marketing a diverse range of healthcare solutions. Their primary focus is on addressing musculoskeletal disorders for patients worldwide. Their extensive portfolio includes a variety of spinal products. These encompass traditional fusion implants like pedicle screw and rod systems, plating systems, intervertebral spacers, and corpectomy devices, all designed to treat conditions such as degenerative diseases, deformities, tumors, and trauma. Furthermore, they offer advanced motion preservation technologies, including dynamic stabilization, total disc replacement, and interspinous distraction devices. The company also provides interventional pain management options for vertebral compression fractures, alongside a selection of regenerative biologic products such as allografts and synthetic alternatives. Beyond spinal care, Globus Medical manufactures solutions for orthopedic trauma, featuring products like fracture plates, compression screws, intramedullary nails, and external fixation systems. They also specialize in hip and knee joint reconstruction, offering modular hip stems, acetabular cups, and various knee arthroplasty implants, including posterior stabilizing and cruciate retaining designs. Additionally, the company engages in the distribution of human cell, tissue, and other cellular and tissue-based products. Established in 2003, Globus Medical, Inc. maintains its corporate headquarters in Audubon, Pennsylvania.

Audubon, PA

6,000 employees

www.globusmedical.com

Healthcare / Medical - Devices

Sector: Healthcare
Industry: Medical - Devices
CEO: Keith W. Pfeil

View full financials

GMED EBITDA Margin Metrics

EBITDA MARGIN

31.91%

EBITDA MARGIN AVG TTM

27.68%

EBITDA MARGIN AVG 3Y

21.84%

EBITDA MARGIN AVG 5Y

23.67%

EBITDA MARGIN AVG 10Y

28.58%

EBITDA MARGIN AVG 15Y

30.54%

EBITDA MARGIN AVG 20Y

N/A

CURRENT VS TTM AVG

+15.26%

CURRENT VS 3Y AVG

+46.07%

CURRENT VS 5Y AVG

+34.78%

CURRENT VS 10Y AVG

+11.64%

CURRENT VS 15Y AVG

+4.48%

CURRENT VS 20Y AVG

N/A

NAME	MARKET CAP	EBITDA MARGIN	TTM	3Y	5Y
Globus Medical, Inc. (GMED)	$11.13B	31.91%	27.68%	21.84%	23.67%
Bio-Techne Corporation (TECH)vs ›	$11.35B	28.74%	23.07%	27.33%	30.04%
Align Technology, Inc. (ALGN)vs ›	$11.38B	19.75%	19.29%	19.87%	21.06%
DaVita Inc. (DVA)vs ›	$11.48B	19.98%	20.97%	19.78%	20.10%
Bio-Rad Laboratories, Inc. (BIO)vs ›	$10.50B	18.42%	17.41%	19.12%	20.05%
Universal Health Services, Inc. (UHS)vs ›	$10.45B	15.05%	14.69%	13.35%	14.10%
Encompass Health Corporation (EHC)vs ›	$11.86B	23.27%	22.46%	26.66%	22.37%
Molina Healthcare, Inc. (MOH)vs ›	$10.37B	2.15%	3.41%	4.20%	4.49%
Henry Schein, Inc. (HSIC)vs ›	$10.28B	8.11%	8.11%	8.28%	8.19%
The Ensign Group, Inc. (ENSG)vs ›	$10.11B	10.47%	10.43%	10.38%	10.85%

NAME

MARKET CAP

EBITDA MARGIN

TTM

Globus Medical, Inc. (GMED)

$11.13B

31.91%

27.68%

21.84%

23.67%

Bio-Techne Corporation (TECH)vs ›

$11.35B

28.74%

23.07%

27.33%

30.04%

Align Technology, Inc. (ALGN)vs ›

$11.38B

19.75%

19.29%

19.87%

21.06%

DaVita Inc. (DVA)vs ›

$11.48B

19.98%

20.97%

19.78%

20.10%

Bio-Rad Laboratories, Inc. (BIO)vs ›

$10.50B

18.42%

17.41%

19.12%

20.05%

Universal Health Services, Inc. (UHS)vs ›

$10.45B

15.05%

14.69%

13.35%

14.10%

Encompass Health Corporation (EHC)vs ›

$11.86B

23.27%

22.46%

26.66%

22.37%

Molina Healthcare, Inc. (MOH)vs ›

$10.37B

2.15%

3.41%

4.20%

4.49%

Henry Schein, Inc. (HSIC)vs ›

$10.28B

8.11%

8.28%

8.19%

The Ensign Group, Inc. (ENSG)vs ›

$10.11B

10.47%

10.43%

10.38%

10.85%

EBITDA Margin FAQ

What is the EBITDA margin for Globus Medical, Inc. (GMED)?

The EBITDA margin for GMED stock is 31.91%.

Is Globus Medical, Inc.'s EBITDA margin high or low?

The EBITDA margin of 31.91% is 35% above its 5-year average of 23.67%, near the high end of its 5-year range (9.85%–32.13%).

What is the TTM average EBITDA margin for Globus Medical, Inc. (GMED)?

The TTM average EBITDA margin for GMED stock is 27.68%.

What is the 3Y average EBITDA margin for Globus Medical, Inc. (GMED)?

The 3Y average EBITDA margin for GMED stock is 21.84%.

What is the 5Y average EBITDA margin for Globus Medical, Inc. (GMED)?

The 5Y average EBITDA margin for GMED stock is 23.67%.

What is the 10Y average EBITDA margin for Globus Medical, Inc. (GMED)?

The 10Y average EBITDA margin for GMED stock is 28.58%.

What is the 15Y average EBITDA margin for Globus Medical, Inc. (GMED)?

The 15Y average EBITDA margin for GMED stock is 30.54%.

DATE	EBITDA MARGIN
2026-06-30	31.91%
2026-03-31	30.72%
2025-12-31	29.28%
2025-09-30	26.80%
2025-06-30	19.69%
2025-03-31	27.27%
2024-12-31	19.55%
2024-09-30	18.39%
2024-06-30	17.98%
2024-03-31	10.43%
2023-12-31	13.18%
2023-09-30	9.85%
2023-06-30	28.90%
2023-03-31	26.93%
2022-12-31	25.84%
2022-09-30	30.41%
2022-06-30	32.13%
2022-03-31	27.45%
2021-12-31	14.01%
2021-09-30	30.51%
2021-06-30	25.90%
2021-03-31	31.54%
2020-12-31	32.32%
2020-09-30	30.69%
2020-06-30	-7.03%
2020-03-31	22.57%
2019-12-31	30.25%
2019-09-30	28.35%
2019-06-30	28.65%
2019-03-31	26.97%
2018-12-31	28.17%
2018-09-30	28.81%
2018-06-30	29.93%
2018-03-31	31.60%
2017-12-31	32.18%
2017-09-30	30.73%
2017-06-30	31.54%
2017-03-31	33.73%
2016-12-31	34.93%
2016-09-30	33.53%
2016-06-30	32.69%
2016-03-31	35.56%
2015-12-31	43.77%
2015-09-30	34.14%
2015-06-30	32.14%
2015-03-31	33.58%
2014-12-31	35.20%
2014-09-30	34.21%
2014-06-30	32.53%
2014-03-31	32.87%
2013-12-31	32.05%
2013-09-30	32.06%
2013-06-30	14.89%
2013-03-31	32.22%
2012-12-31	33.54%
2012-09-30	33.42%
2012-06-30	36.54%
2012-03-31	34.25%
2011-12-31	32.34%
2011-09-30	36.61%
2011-06-30	34.43%
2011-03-31	34.66%

DATE

EBITDA MARGIN

2026-06-30

31.91%

2026-03-31

30.72%

2025-12-31

29.28%

2025-09-30

26.80%

2025-06-30

19.69%

2025-03-31

27.27%

2024-12-31

19.55%

2024-09-30

18.39%

2024-06-30

17.98%

2024-03-31

10.43%

2023-12-31

13.18%

2023-09-30

9.85%

2023-06-30

28.90%

2023-03-31

26.93%

2022-12-31

25.84%

2022-09-30

30.41%

2022-06-30

32.13%

2022-03-31

27.45%

2021-12-31

14.01%

2021-09-30

30.51%

2021-06-30

25.90%

2021-03-31

31.54%

2020-12-31

32.32%

2020-09-30

30.69%

2020-06-30

-7.03%

2020-03-31

22.57%

2019-12-31

30.25%

2019-09-30

28.35%

2019-06-30

28.65%

2019-03-31

26.97%

2018-12-31

28.17%

2018-09-30

28.81%

2018-06-30

29.93%

2018-03-31

31.60%

2017-12-31

32.18%

2017-09-30

30.73%

2017-06-30

31.54%

2017-03-31

33.73%

2016-12-31

34.93%

2016-09-30

33.53%

2016-06-30

32.69%

2016-03-31

35.56%

2015-12-31

43.77%

2015-09-30

34.14%

2015-06-30

32.14%

2015-03-31

33.58%

2014-12-31

35.20%

2014-09-30

34.21%

2014-06-30

32.53%

2014-03-31

32.87%

2013-12-31

32.05%

2013-09-30

32.06%

2013-06-30

14.89%

2013-03-31

32.22%

2012-12-31

33.54%

2012-09-30

33.42%

2012-06-30

36.54%

2012-03-31

34.25%

2011-12-31

32.34%

2011-09-30

36.61%

2011-06-30

34.43%

2011-03-31

34.66%

EBITDA Margin: 31.91%

GMED EBITDA Margin

GMED Average EBITDA Margin Chart

GMED Current vs Average EBITDA Margin Chart

GMED EBITDA Margin Metrics

GMED Competitors' EBITDA Margin

Margin Comparison

EBITDA Margin Formula & Definition

EBITDA Margin FAQ

GMED EBITDA Margin History

Related Metrics